Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study-Reference-Cited by-同舟云学术

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

Published:2010-02 Issue:2 Volume:11 Page:155-164
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Wolchok Jedd D,Neyns Bart,Linette Gerald,Negrier Sylvie,Lutzky Jose,Thomas Luc,Waterfield William,Schadendorf Dirk,Smylie Michael,Guthrie Troy,Grob Jean-Jacques,Chesney Jason,Chin Kevin,Chen Kun,Hoos Axel,O'Day Steven J,Lebbé Celeste

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Management of cutaneous melanoma;Tsao;N Engl J Med,2004

2. Cutaneous melanoma: available therapy for metastatic disease;Tarhini;Dermatol Ther,2006

3. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group;Bedikian;J Clin Oncol,2006

4. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol,1999

5. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma;Sasse;Cochrane Database Syst Rev,2007

Cited by 1047 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of concomitant therapy with ademetionine in antitumor drug therapy: A review;Consilium Medicum;2024-08-30

2. Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer;Journal of Experimental Medicine;2024-08-27

3. Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives;Biomarker Research;2024-07-30

4. Ligand-associated activation of vitamin D receptors and potential points of application of its effects in the morphogenesis of immune inflammation: Literature review;Acta Biomedica Scientifica;2024-07-22

5. Immunotherapy-induced hepatitis in metastatic colorectal cancer: a systematic review and meta-analysis;Baylor University Medical Center Proceedings;2024-07-08